Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Misbehaving macrophages in the pathogenesis of psoriasis
Rachael A. Clark, Thomas S. Kupper
Rachael A. Clark, Thomas S. Kupper
Published August 1, 2006
Citation Information: J Clin Invest. 2006;116(8):2084-2087. https://doi.org/10.1172/JCI29441.
View: Text | PDF
Commentary Article has an altmetric score of 3

Misbehaving macrophages in the pathogenesis of psoriasis

  • Text
  • PDF
Abstract

Psoriasis is a chronic inflammatory skin disease unique to humans. In this issue of the JCI, 2 studies of very different mouse models of psoriasis both report that macrophages play a key role in inducing psoriasis-like skin disease. Psoriasis is clearly a polygenic, inherited disease of uncontrolled cutaneous inflammation. The debate that currently rages in the field is whether psoriasis is a disease of autoreactive T cells or whether it reflects an intrinsic defect within the skin — or both. However, these questions have proven difficult to dissect using molecular genetic tools. In the current studies, the authors have used 2 different animal models to address the role of macrophages in disease pathogenesis: Wang et al. use a mouse model in which inflammation is T cell dependent, whereas the model used by Stratis et al. is T cell independent (see the related articles beginning on pages 2105 and 2094, respectively). Strikingly, both groups report an important contribution by macrophages, implying that macrophages can contribute to both epithelial-based and T cell–mediated pathways of inflammation.

Authors

Rachael A. Clark, Thomas S. Kupper

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2014 2013 2012 2011 2009 2008 2006 Total
Citations: 3 7 5 6 6 4 3 4 2 2 2 2 1 1 2 2 1 53
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (53)

Title and authors Publication Year
Roles for Exosomes in the Pathogenesis, Drug Delivery and Therapy of Psoriasis
Chen Y, Liu H, He Y, Yang B, Lu W, Dai Z
Pharmaceutics 2025
Histone Modifications and DNA Methylation in Psoriasis: A Cellular Perspective.
Pan J, Chen S, Chen X, Song Y, Cheng H
Clinical reviews in allergy & immunology 2025
Macrophage polarization in disease therapy: insights from astragaloside IV and cycloastragenol
Xiong BB, Zhuo YM, Wang H, Zheng QL, Tang F, Huang Q, Yao M
Frontiers in Pharmacology 2025
A co-assembly platform engaging macrophage scavenger receptor A for lysosome-targeting protein degradation.
Wang Q, Yang X, Yuan R, Shen A, Wang P, Li H, Zhang J, Tian C, Jiang Z, Li W, Dong S
Nature Communications 2024
Integrative analysis of RNA-sequencing and microarray for the identification of adverse effects of UVB exposure on human skin.
Jang Y, Na HW, Shin DY, Lee J, Han JP, Kim HS, Kim SJ, Choi EJ, Lee C, Hong YD, Kim HJ, Seo YR
Frontiers in public health 2024
Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review.
Mehta H, Narang T, Dogra S, Handa S, Hatwal J, Batta A
Vascular Health and Risk Management 2024
Macrophage Functions in Psoriasis: Lessons from Mouse Models
Nazimek K, Bryniarski K
International journal of molecular sciences 2024
Integrated bioinformatics combined with machine learning to analyze shared biomarkers and pathways in psoriasis and cervical squamous cell carcinoma
Liu L, Yin P, Yang R, Zhang G, Wu C, Zheng Y, Wu S, Liu M
Frontiers in immunology 2024
NETosis of psoriasis: a critical step in amplifying the inflammatory response.
Zhang J, Feng Y, Shi D
Frontiers in immunology 2024
Exploring shared mechanisms between ulcerative colitis and psoriasis and predicting therapeutic natural compounds through bioinformatics and molecular docking
Yang Y, Gong Z, Yang J, Cai Y, Hong S, Mao W, Guo Z, Qiu M, Fan Z, Cui B
Heliyon 2024
Transcriptional regulation on effector T cells in the pathogenesis of psoriasis.
Qu Y, Li D, Xiong H, Shi D
European Journal of Medical Research 2023
M2‐like macrophages polarized by Foxp3− Treg‐of‐B cells ameliorate imiquimod‐induced psoriasis
Huang J, Lin Y, Wang L, Chiang B
Journal of Cellular and Molecular Medicine 2023
Pharmacogenomics on the Treatment Response in Patients with Psoriasis: An Updated Review.
Wang CY, Wang CW, Chen CB, Chen WT, Chang YC, Hui RC, Chung WH
International journal of molecular sciences 2023
Topical Diacerein Decreases Skin and Splenic CD11c(+) Dendritic Cells in Psoriasis.
Brunner SM, Ramspacher A, Rieser C, Leitner J, Heil H, Ablinger M, Tevini J, Wimmer M, Koller A, Piñón Hofbauer J, Felder TK, Bauer JW, Kofler B, Lang R, Wally V
International journal of molecular sciences 2023
Identification of PANoptosis-related biomarkers and immune infiltration characteristics in psoriasis
Lu L, Zhang B, Shi M, Liu A
Medicine 2023
cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment
S Mishra, M Charan, R Shukla, P Agarwal, S Misri, A Verma, D Ahirwar, J Siddiqui, K Kaul, N Sahu, K Vyas, A Garg, A Khan, W Miles, J Song, N Bhutani, R Ganju
Journal of Experimental & Clinical Cancer Research 2022
Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis.
Kamata M, Tada Y
Frontiers in immunology 2022
TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease.
Vickman RE, Aaron-Brooks L, Zhang R, Lanman NA, Lapin B, Gil V, Greenberg M, Sasaki T, Cresswell GM, Broman MM, Paez JS, Petkewicz J, Talaty P, Helfand BT, Glaser AP, Wang CH, Franco OE, Ratliff TL, Nastiuk KL, Crawford SE, Hayward SW
Nature Communications 2022
The phytochemical profiling, pharmacological activities, and safety of malva sylvestris: a review
Batiha GE, Tene ST, Teibo JO, Shaheen HM, Oluwatoba OS, Teibo TK, Al-kuraishy HM, Al-Garbee AI, Alexiou A, Papadakis M
Naunyn-Schmiedeberg's Archives of Pharmacology 2022
Transcriptional inhibition of STAT1 functions in the nucleus alleviates Th1 and Th17 cell-mediated inflammatory diseases.
Park J, Son MJ, Ho CC, Lee SH, Kim Y, An J, Lee SK
Frontiers in immunology 2022
Iontophoresis of Biological Macromolecular Drugs.
Hasan M, Khatun A, Kogure K
Pharmaceutics 2022
Cell-Inspired Biomaterials for Modulating Inflammation
EC Bender, CA Kraynak, W Huang, LJ Suggs
Tissue Engineering Part B: Reviews 2021
Interferon Kappa Is a Rheostat for Development of Psoriasiform Inflammation
M Gharaee-Kermani, SN Estadt, LC Tsoi, SJ Wolf, J Liu, X Xing, J Theros, TJ Reed, L Lowe, D Gruszka, NL Ward, JE Gudjonsson, JM Kahlenberg
Journal of Investigative Dermatology 2021
2,4-Dimethoxy-6-Methylbenzene-1,3-diol, a Benzenoid From Antrodia cinnamomea, Mitigates Psoriasiform Inflammation by Suppressing MAPK/NF-κB Phosphorylation and GDAP1L1/Drp1 Translocation.
Chuang SY, Chen CY, Yang SC, Alalaiwe A, Lin CH, Fang JY
Frontiers in immunology 2021
Green Phellodendri Chinensis Cortex-based carbon dots for ameliorating imiquimod-induced psoriasis-like inflammation in mice.
Zhang M, Cheng J, Hu J, Luo J, Zhang Y, Lu F, Kong H, Qu H, Zhao Y
Journal of nanobiotechnology 2021
DNA Copy Number Variation Associated with Anti-tumour Necrosis Factor Drug Response and Paradoxical Psoriasiform Reactions in Patients with Moderate-to-severe Psoriasis.
Sanz-Garcia A, Reolid A, Fisas LH, Muñoz-Aceituno E, Llamas-Velasco M, Sahuquillo-Torralba A, Botella-Estrada R, García-Martínez J, Navarro R, Daudén E, Abad-Santos F, Ovejero-Benito MC
Acta Dermato Venereologica 2021
Identification of Hub Genes and Immune Infiltration in Psoriasis by Bioinformatics Method.
Su W, Wei Y, Huang B, Ji J
Frontiers in Genetics 2021
Lysophosphatidic Acid Receptor 5 Contributes to Imiquimod-Induced Psoriasis-Like Lesions through NLRP3 Inflammasome Activation in Macrophages
BP Gaire, CH Lee, W Kim, A Sapkota, DY Lee, JW Choi
Cells 2020
Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation
S Thatikonda, V Pooladanda, DK Sigalapalli, C Godugu
Cell Death and Disease 2020
Regulating the Polarization of Macrophages: A Promising Approach to Vascular Dermatosis
H Peng, D Xian, J Liu, S Pan, R Tang, J Zhong
Journal of Immunology Research 2020
Single-cell RNA-Seq reveals the transcriptional landscape and heterogeneity of skin macrophages in Vsir -/- murine psoriasis
C Qie, J Jiang, W Liu, X Hu, W Chen, X Xie, J Liu
Theranostics 2020
Function and Regulation of IL-36 Signaling in Inflammatory Diseases and Cancer Development
D Queen, C Ediriweera, L Liu
Frontiers in Cell and Developmental Biology 2019
Phosphatidylglycerol Inhibits Toll-Like Receptor–Mediated Inflammation by Danger-Associated Molecular Patterns
V Choudhary, R Uaratanawong, RR Patel, H Patel, W Bao, B Hartney, E Cohen, X Chen, Q Zhong, CM Isales, WB Bollag
Journal of Investigative Dermatology 2019
The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis
Madonna, Girolomoni, Dinarello, Albanesi
International journal of molecular sciences 2019
Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis
Yvonne Baumer, Qimin Ng, Gregory Sanda, Amit Dey, Heather Teague, Alexander Sorokin, Pradeep Dagur, Silverman Joanna, Charlotte Harrington, Justin Rodante, Shawn Rose, Nevin Varghese, Agastya Belur, Aditya Goyal, Joel M. Gelfand, Danielle Springer, Christopher Bleck, Crystal Thomas, Zu Xi Yu, Mårten CG Winge, Howard Kruth, Peter Marinkovich, Aditya Joshi, Martin Playford, Nehal Mehta
JCI Insight 2018
Potential Immunological Links Between Psoriasis and Cardiovascular Disease
AP Sajja, AA Joshi, HL Teague, AK Dey, NN Mehta
Frontiers in immunology 2018
IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis
C Bridgewood, GW Fearnley, A Berekmeri, P Laws, T Macleod, S Ponnambalam, M Stacey, A Graham, M Wittmann
Frontiers in immunology 2018
Chitosan-based nanoformulated (–)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis
JC Chamcheu, IA Siddiqui, VM Adhami, S Esnault, DJ Bharali, AS Babatunde, S Adame, RJ Massey, GS Wood, BJ Longley, SA Mousa, H Mukhtar
International Journal of Nanomedicine 2018
Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice
YJ Jeon, SK Sah, HS Yang, JH Lee, J Shin, TY Kim
Experimental & molecular medicine 2017
Contribution of In Vivo and Organotypic 3D Models to Understanding the Role of Macrophages and Neutrophils in the Pathogenesis of Psoriasis
I Lorthois, D Asselineau, N Seyler, R Pouliot
Mediators of Inflammation 2017
Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA
JL Cohen, Y Shen, M Aouadi, P Vangala, M Tencerova, SU Amano, SM Nicoloro, JC Yawe, MP Czech
Molecular Pharmaceutics 2016
Current knowledge on psoriasis and autoimmune diseases
T McCormick, N Ayala-Fontanez, D Soler
Psoriasis: Targets and Therapy 2016
Tumor Progression Locus 2 (Tpl2) Kinase Promotes Chemokine Receptor Expression and Macrophage Migration during Acute Inflammation
SM Rowley, T Kuriakose, LM Dockery, T Tran-Ngyuen, AD Gingerich, L Wei, WT Watford
The Journal of biological chemistry 2014
Topical application of delphinidin reduces psoriasiform lesions in the flaky skin mouse model by inducing epidermal differentiation and inhibiting inflammation
HC Pal, JC Chamcheu, VM Adhami, GS Wood, CA Elmets, H Mukhtar, F Afaq
The British journal of dermatology 2014
Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice
I Lerner, E Zcharia, T Neuman, E Hermano, AM Rubinstein, I Vlodavsky, M Elkin
Cellular and Molecular Life Sciences 2013
Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases.
Zhang Z, Tsai PC, Ramezanli T, Michniak-Kohn BB
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 2013
Development of paclitaxel-TyroSpheres for topical skin treatment.
Kilfoyle BE, Sheihet L, Zhang Z, Laohoo M, Kohn J, Michniak-Kohn BB
Journal of Controlled Release 2012
Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice
Q Li, F Ke, W Zhang, X Shen, Q Xu, H Wang, XZ Yu, Q Leng, H Wang
PloS one 2011
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Translational Perspectives on Psoriatic Arthritis
RITCHLIN CT, PROULX S, SCHWARZ ES
The Journal of rheumatology. Supplement 2009
Sunlight triggers cutaneous lupus through a CSF-1-dependent mechanism in MRL-Fas(lpr) mice
J Menke, MY Hsu, KT Byrne, JA Lucas, WA Rabacal, BP Croker, XH Zong, ER Stanley, VR Kelley
Journal of immunology (Baltimore, Md. : 1950) 2008
Chemokine receptor antagonists: overcoming developmental hurdles
R Horuk
Nature Reviews Drug Discovery 2008
Immunologic misbehaviour in psoriasis
Ingo Haase
Journal of Clinical Investigation 2006

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
86 readers on Mendeley
See more details